Science & Enterprise subscription

Follow us on Twitter

  • An engineering group found a way to adapt a CPAP machine into a mechanical ventilator, a device for people needing… https://t.co/tJcdzaLspJ
    about 17 hours ago
  • New post on Science and Enterprise: Univ. Engineers Convert CPAP into Ventilator https://t.co/atwZ62PHU0 #Science #Business
    about 17 hours ago
  • A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 inf… https://t.co/RT5znygGYm
    about 23 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccine in Development, Trial Planned https://t.co/CxTssHGlFw #Science #Business
    about 23 hours ago
  • A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
    about 2 days ago

Please share Science & Enterprise

Trial to Test Electronic-Aided Covid-19 Vaccine

SARS-Cov-2 virus

A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections. . . . → Read More: Trial to Test Electronic-Aided Covid-19 Vaccine

Engineered Blood Cells Created for Cancer Therapies

Macrophage

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies

Network Funding Tech To Boost Ovarian Cancer Care

Tablet and laptop

An alliance of cancer centers in the U.S. is supporting four projects developing technologies for improving care for patients with advanced ovarian cancer. . . . → Read More: Network Funding Tech To Boost Ovarian Cancer Care

Venom-Aided Immunotherapy Designed for Brain Tumors

Death stalker scorpion

Cancer researchers developed engineered immune-system cells, helped by peptides from scorpion venom, that in lab mice bind more reliably to brain tumor cells. . . . → Read More: Venom-Aided Immunotherapy Designed for Brain Tumors

Engineered Bacteria Deliver Cancer Immunotherapy

E. coli

Escherichia coli, or E. coli, bacteria (National Institute of Allergy and Infectious Diseases)

13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of . . . → Read More: Engineered Bacteria Deliver Cancer Immunotherapy

Synthetic Cell Matrix Devised for Cancer Drug Testing

Honeycomb scaffold

A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs. . . . → Read More: Synthetic Cell Matrix Devised for Cancer Drug Testing

Skin Cancer Apps Shown Misleading, Unreliable

Phone photo

A review of smartphone apps that photograph and purport to analyze skin conditions for signs of cancer shows the apps are unreliable in detecting cancer. . . . → Read More: Skin Cancer Apps Shown Misleading, Unreliable

Blood Cancers Respond to Cord Blood Cells

Katy Rezvani

A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood. . . . → Read More: Blood Cancers Respond to Cord Blood Cells

Liquid Biopsy, A.I. Detect Four Cancers

Blood sample tubes

A single blood test analyzed by machine learning is shown in tests with cancer patients to detect the presence of four types of solid tumor cancers. . . . → Read More: Liquid Biopsy, A.I. Detect Four Cancers

Organ Chip Systems Simulate Full Body Drug Responses

Liver chip device

A robotic system that ties together multiple chip devices representing different human organs can test for drug effects on patients without affecting the individuals. . . . → Read More: Organ Chip Systems Simulate Full Body Drug Responses